{"altmetric_id":20759189,"counts":{"readers":{"mendeley":0,"citeulike":0,"connotea":0},"total":{"posts_count":4},"twitter":{"unique_users_count":4,"unique_users":["JWatch","kdahal57","amuqawed","MedicalLetter"],"posts_count":4}},"selected_quotes":["For #UlcerativeColitis, experimental monoclonal antibody shows promise. @TheLancet #IBD"],"citation":{"altmetric_jid":"4f6fa62b3cf058f610007f3d","authors":["Douglas K. Rex, MD"],"doi":"10.1056\/nejm-jw.na44189","first_seen_on":"2017-06-01T16:41:27+00:00","issns":["1533-7820"],"journal":"Journal Watch","last_mentioned_on":1496421320,"links":["http:\/\/www.jwatch.org\/na44189\/2017\/05\/23\/anti-madcam-antibodies-effective-ulcerative-colitis-phase"],"pubdate":"2017-05-23T00:00:00+00:00","publisher":"Journal Watch","title":"Anti-MAdCAM Antibodies Effective for Ulcerative Colitis in Phase II Trial","type":"article"},"altmetric_score":{"score":1.5,"score_history":{"1y":1.5,"6m":1.5,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":1.5},"context_for_score":{"all":{"total_number_of_other_articles":8307635,"mean":7.0030489970953,"rank":3933190,"this_scored_higher_than_pct":50,"this_scored_higher_than":4189927,"rank_type":"exact","sample_size":8307635,"percentile":50},"similar_age_3m":{"total_number_of_other_articles":240863,"mean":12.176351545698,"rank":111548,"this_scored_higher_than_pct":50,"this_scored_higher_than":122058,"rank_type":"exact","sample_size":240863,"percentile":50},"this_journal":{"total_number_of_other_articles":11645,"mean":4.2443873239437,"rank":6235,"this_scored_higher_than_pct":43,"this_scored_higher_than":5018,"rank_type":"exact","sample_size":11645,"percentile":43},"similar_age_this_journal_3m":{"total_number_of_other_articles":711,"mean":5.3402535211268,"rank":413,"this_scored_higher_than_pct":38,"this_scored_higher_than":277,"rank_type":"exact","sample_size":711,"percentile":38}}},"demographics":{"poster_types":{"member_of_the_public":2,"practitioner":2},"users":{"twitter":{"cohorts":{"Practitioners (doctors, other healthcare professionals)":2,"Members of the public":2}}},"geo":{"twitter":{"US":3,"SA":1}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/JWatch\/statuses\/870319333364432896","license":"gnip","citation_ids":[20759189],"posted_on":"2017-06-01T16:41:13+00:00","author":{"name":"NEJM Journal Watch","url":"http:\/\/www.jwatch.org","image":"https:\/\/pbs.twimg.com\/profile_images\/378800000049399270\/f5db8f1f9bb928c1f4c586c419bde230_normal.png","description":"Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.","id_on_source":"JWatch","tweeter_id":"25952049","geo":{"lt":42.37649,"ln":-71.23561,"country":"US"},"followers":13376},"tweet_id":"870319333364432896"},{"url":"http:\/\/twitter.com\/kdahal57\/statuses\/870481629533401088","license":"gnip","rt":["JWatch"],"citation_ids":[20759189],"posted_on":"2017-06-02T03:26:07+00:00","author":{"name":"kumud dahal","image":"https:\/\/pbs.twimg.com\/profile_images\/2949821637\/24dcca3db72b2a583a2596053ac8f170_normal.jpeg","description":"Interests: Infection in compromised hosts HIV\/ Hep C Tropical Infections Infectious Disease epidemiology","id_on_source":"kdahal57","tweeter_id":"552644651","geo":{"lt":40.00032,"ln":-89.25037,"country":"US"},"followers":180},"tweet_id":"870481629533401088"},{"url":"http:\/\/twitter.com\/amuqawed\/statuses\/870485705008402432","license":"gnip","rt":["JWatch"],"citation_ids":[20759189],"posted_on":"2017-06-02T03:42:19+00:00","author":{"name":"Abdullah Muqawed","image":"https:\/\/pbs.twimg.com\/profile_images\/589826867764432896\/Rp3uUmBp_normal.jpg","description":"Resident, Internal Medicine @ KFMC","id_on_source":"amuqawed","tweeter_id":"2591101482","geo":{"lt":24.68773,"ln":46.72185,"country":"SA"},"followers":237},"tweet_id":"870485705008402432"},{"url":"http:\/\/twitter.com\/MedicalLetter\/statuses\/870680240351092737","license":"gnip","rt":["JWatch"],"citation_ids":[20759189],"posted_on":"2017-06-02T16:35:20+00:00","author":{"name":"The Medical Letter","url":"http:\/\/www.medicalletter.org","image":"https:\/\/pbs.twimg.com\/profile_images\/571041430861139968\/01yBO_lj_normal.png","description":"The Medical Letter, Inc. is a nonprofit organization that publishes critical appraisals of new drugs and comparative reviews of previously approved drugs.","id_on_source":"MedicalLetter","tweeter_id":"110717075","geo":{"lt":40.91149,"ln":-73.78235,"country":"US"},"followers":1926},"tweet_id":"870680240351092737"}]}}